Rabia Gurses Ozden - Jan 31, 2024 Form 4 Insider Report for OCULAR THERAPEUTIX, INC (OCUL)

Signature
/s/ Donald Notman, Attorney-in-Fact for Rabia Gurses Ozden
Stock symbol
OCUL
Transactions as of
Jan 31, 2024
Transactions value $
-$38,432
Form type
4
Date filed
2/2/2024, 07:02 PM
Previous filing
Jul 11, 2023
Next filing
Feb 6, 2024

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction OCUL Common Stock Sale -$38.4K -7.76K -7.72% $4.95 92.8K Jan 31, 2024 Direct F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents shares of common stock of Ocular Therapeutix, Inc. (the "Corporation") sold, pursuant to a durable automatic sales instruction letter effecting the sell-to-cover election of the reporting person to satisfy tax withholding obligations, in connection with the vesting of restricted stock units on January 30, 2024. The sales do not represent a discretionary trade by the reporting person.
F2 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $4.83 to $5.04, inclusive. The reporting person undertakes to provide to the Corporation, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote (2) to this Form 4.